(Q54346247)

28 May 2018

title

Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. (English)

1 reference

28 May 2018

Yukino Chiba

4

0 references

Yoichiro Iwakura

object named as

Yoichiro Iwakura

7

0 references

author name string

Mingli Xu

1

1 reference

28 May 2018

Noriko Morishima

2

1 reference

28 May 2018

Izuru Mizoguchi

3

1 reference

28 May 2018

Koji Fujita

5

1 reference

28 May 2018

Masahiko Kuroda

6

1 reference

28 May 2018

Daniel J Cua

8

1 reference

28 May 2018

Koji Yasutomo

9

1 reference

28 May 2018

Junichiro Mizuguchi

10

1 reference

28 May 2018

Takayuki Yoshimoto

11

1 reference

28 May 2018

language of work or name

English

0 references

publication date

31 August 2011

1 reference

28 May 2018

European Journal of Immunology

published in

1 reference

28 May 2018

volume

41

1 reference

28 May 2018

issue

10

1 reference

28 May 2018

page(s)

2828-2839

1 reference

28 May 2018

Reconciling id, ego, and superego within interleukin-23.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Biology of interleukin-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

IL-22 and inflammation: leukin' through a glass onion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

IL-22 in mucosal immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

The dual nature of TH17 cells: shifting the focus to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

The role of Notch in tumorigenesis: oncogene or tumour suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Notch signalling during peripheral T-cell activation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

STAT3 regulates cytokine-mediated generation of inflammatory helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Stat3 and Stat4 direct development of IL-17-secreting Th cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Halothane-induced liver injury is mediated by interleukin-17 in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

7 January 2021

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

7 January 2021

Murine NKT cells produce Th17 cytokine interleukin-22

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

7 January 2021

Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

7 January 2021

Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141291

7 January 2021

Identifiers

DOI

10.1002/EJI.201141291

1 reference

28 May 2018

1 reference

28 May 2018